Personalised care,
better oncology.
Doctor Symeon Eleftheriadis is a medical oncologist trained in the UK’s NHS, specialising in cancer immunotherapy through the European ATTRACT programme.
NHS-trained
Specialty training and clinical experience across nine hospitals in the United Kingdom.
ATTRACT immunotherapy
Advanced training in cell therapy at The Christie, Manchester.
Second opinion
A straight, transparent review of every treatment option — without rushing.
A career devoted
to modern oncology.
A graduate of the Aristotle University of Thessaloniki Medical School, Doctor Eleftheriadis completed his specialty training in NHS public hospitals across the United Kingdom — from Royal Cornwall and Bristol to Northampton General.
For two years he served as a Clinical Research Fellow at The Christie in Manchester, on the European ATTRACT immunotherapy programme — taking part in more than 70 clinical trials.
- Targeted therapies
- Immunotherapy
- Multidisciplinary team
- Supportive care
Comprehensive oncology care
Six fields of expertise, one principle: treatment is shaped around the biology of the tumour and the life of the patient.
Targeted therapies
Molecular profiling of the tumour as a guide: HER2, EGFR, ALK, BRCA, MSI and other biomarkers.
Learn moreImmunotherapy
Anti-PD1 / PD-L1, checkpoint inhibitors and cell-therapy experience from ATTRACT.
Learn moreBreast cancer
Genetic counselling (BRCA1/2), early-stage and metastatic disease, with MDT coordination.
Learn moreLung & thoracic
NSCLC with targeted therapy, SCLC, mesothelioma and thoracic malignancies.
Learn moreGastrointestinal
Colorectal, gastric, oesophageal, hepatobiliary and pancreatic cancers.
Learn moreSupportive care
Pain management, nutrition, psycho-oncology support and palliative care.
Learn more
Two years on the ATTRACT programme.
As a Clinical Research Fellow at Europe’s largest dedicated cancer hospital, under Prof. Robert Hawkins, Doctor Eleftheriadis trained at the cutting edge of cell therapy (CAR-T).
He took part as a Sub-Investigator in more than 50 clinical trials, with secondments at the Netherlands Cancer Institute (Amsterdam) and the University of Cologne.
Care is the treatment.
Enough time
The first visit is not short and does not end with a prescription — there is time for history and questions.
Molecular guidance
Genomic & immunohistochemistry profiling before choosing treatment, so it targets your specific tumour.
Multidisciplinary team
Every case is taken to an MDT — surgeon, radiation oncologist, pathologist, psycho-oncologist.
Full transparency
Every alternative with its real figures — and a second opinion as an ally, not a threat.
“We don’t treat diagnoses — we treat people who have received a diagnosis.”
S. Eleftheriadis, MDWe are here to support you at every step.
First visit or second opinion — book an appointment and start with a straight, thorough conversation.